Visual Electrophysiology Market Status and Prospects 2022-2032

The global Visual Electrophysiology Market is currently valued at US$ 220.3 Mn and is expected to reach US$ 475.3 Mn by 2032, growing at a 7.2% CAGR between 2022 and 2032.

New materials and technology for creating innovative practise solutions are known to significantly contribute to global market growth. Furthermore, visual electrophysiology devices are simple to use, which is likely to lead to an increase in at-home adoption.

Numerous public awareness campaigns are being held to promote regular eye examinations and the early detection of visual disorders. As a result, retinal electrophysiology is expected to dominate the visual electrophysiology market in the not-too-distant future.

The current scenario also sees an increase in funding for government initiatives, research studies, and public awareness campaigns about the benefits of visual electrophysiology.

The ability to identify problems at an early stage is driving the popularity of the visual electrophysiology market. There are start-ups that offer training in techniques and materials for developing innovative solutions. Along these lines, LumiThera Inc. appears to be a medical device start-up specialising in visual electrophysiology.

The primary goal is to create PBM (photo-biomodulation) treatment protocols for patients infected with AMD (Age-related macular degeneration). According to research, AMD is one of the leading causes of blindness in people aged 65 and up. The company offers vision preservation and enhancement treatments, as well as PBM devices for treating ocular disorders and diseases.

At the same time, higher treatment and diagnosis costs, combined with a scarcity of experts, are expected to restrain the visual electrophysiology market. Future Market Insights' latest market study, titled 'Visual Electrophysiology Market,' includes these facts and insights.

Key Takeaways from Visual Electrophysiology Market

  • North America controls 33% of the global market. This could be attributed to increasing research investments. In addition, ocular disorders are becoming more common in this region at an alarming rate.
  • Europe controls more than a quarter of the global market. This could be explained by the rising number of cancer cases in the area. Furthermore, when the patient's physical well-being is at stake, the government is quite proactive.
  • The Asia-Pacific market for visual electrophysiology is expected to grow at the fastest rate. It is led by Japan, where eye health is prioritised.

“The visual electrophysiology market is bound to grow on the back of growing expenditures in the healthcare advancements with an ever-increasing adoption of visual electrophysiology diagnostics procedures”, says an analyst from Future Market Insights.

Competitive Landscape

  • NICE published the final draught guidance in June 2022, recommending 'Farcimab,' a new drug, to help treat visual impairment and sight loss.
  • Konan Medical, in collaboration with Konan Medical USA Inc., announced the release of the 'CellChek 20' novel endothelial imaging system in September 2020, which includes single-button press exam capturing images of the eyes and automated analysis with the new, 100% automated Center Method.
  • LKC Technologies offers its RETeval Device, which includes age-adjusted normative data.
  • To treat cardiac arrhythmias, Biosense Webster, Inc. has visual electrophysiological devices that enable advanced mapping, technical innovation, and data integration.
  • As per type of test, ERG holds the largest market share. This could be credited to advantages like evaluation of both – acquired and hereditary disorders of retina. These diagnoses generally suspect retinitis pigmentose, choroideremia, retinitis pigmentosa sine pigment, congenital stationary night blindness, and achromatopsia. Governments in the advanced economies are also supporting early diagnosis as well as treatment of neurological and visual disorders.
  • By end-user, hospitals lead the visual electrophysiology market. Clinics come in second. This is due to the fact that hospitals can better cope up with new machinery. There are hospitals having an exclusive ‘R&D Department’. This renders them in line with the latest technologies.

Key Segments Profiled in the Visual electrophysiology market

By Test Type: 

  • Electroretinogram (ERG)
  • Multifocal Electroretinogram (mfERG)
  • Electro-Oculogram (EOG)
  • Visual-Evoked Responses (VER)

By Modality:

  • Fixed
  • Portable

By End User: 

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers

Get More Details@ https://www.futuremarketinsights.com/reports/visual-electrophysiology-testing-devices-market

Comments

Post a Comment

Popular posts from this blog

Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

Image
According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033. Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world. Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to prod...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Cognitive Diagnostics Market Projected to Reach Unprecedented Growth by 2033

Image
As per Future Market Insights latest industry analysis, the valuation for the global  Cognitive Diagnostics market sales  is estimated to reach US$ 110.2 Billion in 2023 and is projected to exhibit a CAGR of 8.0% over the forecast period, with an estimated valuation of US$ 238.3 Billion by 2033. Several causes of brain problems or cognitive disorders include closed head injuries, contact with neurotoxins (toxic substances), genetics, infections, strokes, and tumours. Depending on the area of the brain that is impacted, a person may have a certain form of cognitive problem. Communication issues could result from, for instance, a tumour in the speech cisterns of the brain. In another illustration, a brain infection that affects the motor recentres would cause problems with movement. Ageing is also a factor in the development of cognitive problems. Cognitive diagnostics increasingly use digital health technologies like wearables and smartphone apps. These tools can monitor a pati...
Read more